The global machine learning (ML) market in the pharmaceutical industry is expected to see significant growth in the coming years, driven by factors such as increasing complexity of biological data, growing computational power, and industry awareness and education. Major trends include AI-pharma partnerships and collaborations, drug-agnostic therapies, and decentralized clinical trials. Top companies in the market include Amazon, Alphabet, Microsoft, and Dell Technologies.